GoodFellas Big Board Catalyst and Chart Plays

[prokopton]

CBP halt

I think at this point it's reasonable to rule out:

--a 3rd party hatchet job.

--a serious SEC investigation, as we should have heard about it by now.

I'm guessing a buyout or reinstatement of quarterly numbers, which may coincide with the recent press release:

HARBIN, China, Jan. 24, 2013 /PRNewswire/ -- China Botanic Pharmaceutical Inc. (NYSE AMEX: CBP) ("China Botanic" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and Traditional Chinese Medicines ("TCM") in China, today announced the appointment of Mr. Jack Zhao as a member of the Company's Board of Directors. Mr. Zhao will serve as an independent director, the Chairman of the Board's Audit Committee, the Audit Committee Financial Expert, and as a member of the Company's Compensation and the Nomination Committees.